Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicare Rx Law Signed; Six-Month Quiet Period Before First Phase Begins

Executive Summary

The signing of the Medicare prescription drug bill ushers in a six-month period that will be critical in shaping the public perception of the benefit before the first impact of the legislation is felt by seniors

You may also be interested in...



CMS Administrator McClellan Has Long Priority List, $1 Bil. For Expansion

Incoming CMS Administrator McClellan's first challenge will be setting priorities for the agency as it wrestles with multiple mandates from the 2003 Medicare Rx law

CMS Administrator McClellan Has Long Priority List, $1 Bil. For Expansion

Incoming CMS Administrator McClellan's first challenge will be setting priorities for the agency as it wrestles with multiple mandates from the 2003 Medicare Rx law

Medicare Rx Overseer Will Be CMS Deputy Norwalk; Smith Is Acting CMS Head

The first stages of the implementation of the Medicare prescription drug benefit will be overseen by Centers for Medicare & Medicaid Services acting Deputy Director Leslie Norwalk

Related Content

UsernamePublicRestriction

Register

OM013057

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel